Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 22514788)

1.

A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.

Yousefi MK, Folsom TD, Fatemi SH.

J Addict Res Ther. 2011 Dec 20;S4(1). pii: 3045.

2.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743
3.

Varenicline in the treatment of tobacco dependence.

Fagerström K, Hughes J.

Neuropsychiatr Dis Treat. 2008 Apr;4(2):353-63.

4.
5.

Varenicline: for smoking cessation.

Rao J, Shankar PK.

Kathmandu Univ Med J (KUMJ). 2009 Apr-Jun;7(26):162-4. Review.

PMID:
20071853
6.

Efficacy and safety of varenicline for smoking cessation.

Hays JT, Ebbert JO, Sood A.

Am J Med. 2008 Apr;121(4 Suppl 1):S32-42. doi: 10.1016/j.amjmed.2008.01.017. Review.

PMID:
18342165
7.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
8.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
9.
10.

Partial nicotinic acetylcholine (alpha4beta2) agonists as promising new medications for smoking cessation.

Singh J, Budhiraja S.

Indian J Pharmacol. 2008 Oct;40(5):191-6. doi: 10.4103/0253-7613.44150.

11.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
12.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Hays JT, Ebbert JO.

Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Review.

PMID:
21142259
13.

[Effectiveness and safety of varenicline for smoking cessation].

Christalla P, Dewenter M, El-Armouche A.

Dtsch Med Wochenschr. 2012 May;137(18):940-4. doi: 10.1055/s-0032-1304895. Epub 2012 Apr 10. Review. German.

PMID:
22492478
14.

Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.

Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J.

Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.

PMID:
22818870
15.

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.

J Clin Psychiatry. 2012 May;73(5):654-60. doi: 10.4088/JCP.11m07522. Erratum in: J Clin Psychiatry. 2012 Jul;73(7):1035.

PMID:
22697191
16.

Varenicline: a novel pharmacotherapy for smoking cessation.

Jiménez-Ruiz C, Berlin I, Hering T.

Drugs. 2009 Jul 9;69(10):1319-38. doi: 10.2165/00003495-200969100-00003. Review.

PMID:
19583451
18.

Varenicline in smoking cessation.

Tonstad S, Rollema H.

Expert Rev Respir Med. 2010 Jun;4(3):291-9. doi: 10.1586/ers.10.27. Review.

PMID:
20524911
19.
20.

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.

Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD 3rd, Williams KE.

Neuropharmacology. 2007 Mar;52(3):985-94. Epub 2006 Dec 8.

PMID:
17157884
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk